🇺🇸 FDA
Pipeline program

Placebo contains excipients only and is visually indistinguishable from the Telitacicept, Telitacicept injection

RC18G006

Phase 3 small_molecule active

Quick answer

Placebo contains excipients only and is visually indistinguishable from the Telitacicept, Telitacicept injection for Generalized Myasthenia Gravis is a Phase 3 program (small_molecule) at Vor Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Vor Biopharma
Indication
Generalized Myasthenia Gravis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials